← SynDRA
FENOLDOPAM
SynDRA canonical compound SYN0001021 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | DRD1 |
|---|
| Mechanism of action | Dopamine receptor agonist |
|---|
| Indication | hypertension |
|---|
| Disease area | cardiology |
|---|
All known targets
- DRD1
- DRD4
- DRD5
- ADRA1A
- ADRA1B
- ADRA1D
- Adora2b
- DRD2
- Drd1
- Drd2
- GFER
- KDM4E
Mechanisms of action (all sources)
- Dopamine receptor agonist
- DRD1 AGONIST
- Dopamine D1 receptor agonist
- DRD1 FULL AGONIST
- DRD1 PARTIAL AGONIST
- DRD4 FULL AGONIST
- DRD5 FULL AGONIST
Drug classes
- Dopamine Agonists
- Dopaminergic Agonist
- Antihypertensive Agents
- Cardiovascular Agents
- Dopamine Agents
- Neurotransmitter Agents
- Vasodilator Agents
ATC classes
- C01C · CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Cross-references
Synonyms
- fenoldopam hydrobromide
- fenoldopam mesylate
- corlopam
- fenoldopam mesilate
- Carlacor
- SK&F-82526
- SK-82526
- Fenoldopamum
- Fenodopam mesylate
- Fenoldopamum [Latin]
- SKF 82526
- Carlacor (TN)
- Corlopam (TN)
- Fenoldopam (INN);Fenoldopam [INN:BAN]
- SKF 82526-J
- SKF-82526J
- 6-chloro-1-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol
- 9-chloro-5-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol
- SKF-82526
- INU8H2KAWG
- CHEBI:5002
- SK&F 82526J
- DTXCID8023896
- RefChem:56465
- SKF82526J
- C01CA19
- SK&F82526J
- SKF 82526J
- SKF82526
- SK&F82526
- Fenoldopam (INN)
- NCGC00015444-04
- FENOLDOPAM [INN]
- Fenoldopam [INN:BAN]
- MLS001401388
- CAS-67227-56-9
- UNII-INU8H2KAWG
- SMR000469190
Look up FENOLDOPAM in the interactive SynDRA portal →